دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea
Yogesh N. V. Reddy, MD, MSc; David M. Kaye, MBBS, PhD; M. Louis Handoko, MD, PhD;Arno A. van de Bovenkamp, MD; Ryan J. Tedford, MD; Carson Keck, MD; Mads J. Andersen, MD, PhD;Kavita Sharma, MD; Rishi K. Trivedi, MD, PhD; Rickey E. Carter, PhD; Masaru Obokata, MD, PhD;Frederik H. Verbrugge, MD, PhD; Margaret M. Redfield, MD; Barry A. Borlaug, MD
doi : 10.1001/jamacardio.2022.1916
September 2022, Vol 7, No. 9, Pages 882-990
Demographic and Regional Trends of Heart Failure–Related Mortality in Young Adults in the US, 1999-2019
Vardhman Jain, MD; Abdul Mannan Khan Minhas, MD; Alanna A. Morris, MD, MSc; Stephen J. Greene, MD;Ambarish Pandey, MD, MSCS; Sadiya S. Khan, MD; Gregg C. Fonarow, MD; Robert J. Mentz, MD;Javed Butler, MD, MPH, MBA; Muhammad Shahzeb Khan, MD, MSc
Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart FailureThe REVEAL-HF Randomized Clinical Trial
Tariq Ahmad, MD, MPH; Nihar R. Desai, MD, MPH; Yu Yamamoto, MS; Aditya Biswas, MS; Lama Ghazi, MD, PhD; Melissa Martin, MA;Michael Simonov, MD; Ravi Dhar, PhD; Allen Hsiao, MD; Nitu Kashyap, MD; Larry Allen, MD, MHS; Eric J. Velazquez, MD; F. Perry Wilson, MD, MSCE
Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 DiabetesA Prespecified Secondary Analysis of a Randomized Clinical Trial
Kazuma Oyama, MD, MPH, PhD; Itamar Raz, MD; Avivit Cahn, MD; Erica L. Goodrich, MS;Deepak L. Bhatt, MD, MPH; Lawrence A. Leiter, MD; Darren K. McGuire, MD, MHSc; John P. H. Wilding, MD;Ingrid A. M. Gause-Nilsson, MD, PhD; Ofri Mosenzon, MD, MSc; Marc S. Sabatine, MD, MPH; Stephen D. Wiviott, MD
Association of Left Ventricular Remodeling Assessment by Cardiac Magnetic Resonance With Outcomes in Patients With Chronic Aortic Regurgitation
Go Hashimoto, MD; Maurice Enriquez-Sarano, MD; Larissa I. Stanberry, PhD; Felix Oh, MD; Matthew Wang, MD;Keith Acosta, MD; Hirotomo Sato, MD, PhD; Bernardo B. C. Lopes, MD; Miho Fukui, MD, PhD; Santiago Garcia, MD;Mario Goessl, MD; Paul Sorajja, MD; Vinayak N. Bapat, MD; John Lesser, MD; João L. Cavalcante, MD
Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes
Dhaval Kolte, MD, PhD; Bhaskar Bhardwaj, MD; Michael Lu, PhD; Maria C. Alu, MS; Jonathan J. Passeri, MD;Ignacio Inglessis, MD; Gus J. Vlahakes, MD; Santiago Garcia, MD; David J. Cohen, MD, MSc;Brian R. Lindman, MD, MSCI; Susheel Kodali, MD; Vinod H. Thourani, MD; Melissa A. Daubert, MD;Pamela S. Douglas, MD; Wael Jaber, MD; Philippe Pibarot, DVM, PhD; Marie-Annick Clavel, DVM, PhD;Igor F. Palacios, MD; Martin B. Leon, MD; Craig R. Smith, MD; Michael J. Mack, MD; Sammy Elmariah, MD, MPH
Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use
Angela Lowenstern, MD; Anna Hung, PhD; Pratik Manandhar, MS; Zachary K. Wegermann, MD;Samir R. Kapadia, MD; Brian R. Lindman, MD; Kashish Goel, MD; Melissa Levack, MD; Colin M. Barker, MD;Shelby D. Reed, PhD; David J. Cohen, MD; Sreekanth Vemulapalli, MD
Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery DiseaseA Factorial Mendelian Randomization Study
Arjen J. Cupido, MD; Laurens F. Reeskamp, MD, PhD; Aroon D. Hingorani, MD, PhD; Chris Finan, PhD;Folkert W. Asselbergs, MD, PhD; G. Kees Hovingh, MD, PhD; Amand F. Schmidt, PhD
Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing
Lisa M. Dellefave-Castillo, MS; Allison L. Cirino, MS; Thomas E. Callis, PhD; Edward D. Esplin, MD, PhD;John Garcia, PhD; Kathryn E. Hatchell, PhD; Britt Johnson, PhD; Ana Morales, MS; Ellen Regalado, PhD;Susan Rojahn, PhD; Matteo Vatta, PhD; Robert L. Nussbaum, MD; Elizabeth M. McNally, MD, PhD
Age at Diagnosis of Hypertension by Race and Ethnicity in the US From 2011 to 2020
Xiaoning Huang, PhDKristen Lee, MDMichael C. Wang, BANilay S. Shah, MD, MPHSadiya S. Khan, MD, MSc
Earlier Intervention in Asymptomatic Chronic Aortic Regurgitation—Novel Indicators of Myocardial Overload
Vidhu Anand, MBBS1; Rick A. Nishimura, MD1; Vera H. Rigolin, MD2
Left Ventricular Volume and Outcomes in Patients With Chronic Aortic Regurgitation
Robert O. Bonow, MD, MS1,2; Patrick T. O’Gara, MD3,4
Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention
Carl J. Lavie, MD1; Barry A. Franklin, PhD2; Keith C. Ferdinand, MD3
Genetic Testing Panels in Inherited Cardiac Diseases—Does Size Really Matter?
Julia Isbister, MBBS1,2,3; Luciana Sacilotto, MD, PhD4; Christopher Semsarian, MBBS, PhD, MPH1,2,3
Improving Quality Improvement—From Aspiration Toward Empiricism
Andrew S. Oseran, MD, MBA1,2; Rishi K. Wadhera, MD, MPP, MPhil1
Innovation’s Disjointed Path From Approval to Payment—The Case of Embolic Protection Devices for Transcatheter Aortic Valve Replacement
Neel M. Butala, MD, MBA1,2; Andrew S. Oseran, MD, MBA1,2; Robert W. Yeh, MD, MSc1
Advances in Imaging and Targeted Therapies for Recurrent PericarditisA Review
Sachin Kumar, MD; Shameer Khubber, MD; Reza Reyaldeen, MD; Ankit Agrawal, MD; Paul C. Cremer, MD;Massimo Imazio, MD; Deborah H. Kwon, MD; Allan L. Klein, MD
Prosthetic Mechanical Aortic Valve Thrombosis
Joao Boavida, MD1; Espen Ruud, MD1,2; Haseem Ashraf, MD, PhD1,2
Skeletonized Internal Thoracic Artery—Post Hoc Analysis vs Clinical Practice
Gabriele M. Iacona, MD1; Abeel A. Mangi, MD1
Skeletonized Internal Thoracic Artery—Post Hoc Analysis vs Clinical Practice—Reply
Andre Lamy, MD, MHSc1,2; Mario Gaudino, MD, PhD3
NT-proBNP in Early Pregnancy and Future Hypertension—More Explorations Needed
Chunyan Li, MD1; Wenquan Niu, PhD2
NT-proBNP in Early Pregnancy and Future Hypertension—More Explorations Needed—Reply
Alisse Hauspurg, MD1,2; Derek Marsh, MSc3; Janet Catov, PhD1,2
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP
Pradeep Natarajan, MD, MMSc1,2,3,4; Marc S. Sabatine, MD, MPH2,5,6,7
